tripelennamine and Arteriosclerosis Obliterans
tripelennamine has been researched along with Arteriosclerosis Obliterans in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
BAIRD, RJ | 1 |
MIYAGISHIMA, RT | 1 |
LABROSSE, CJ | 1 |
Other Studies
1 other study available for tripelennamine and Arteriosclerosis Obliterans
Article | Year |
---|---|
VASODILATING ACTION OF INTRA-ARTERIAL OXYGEN EMBOLI.
Topics: Acetylcholine; Arteriosclerosis Obliterans; Atropine; Blood Flow Velocity; Blood Pressure; Dogs; Emb | 1964 |